The predominant viewpoint suggests that oxytocin functions as a preventive factor for breast cancer by acting on myoepithelial cells, which relieves the expansion of secretory vesicles and facilitates the elimination of carcinogenic substances, ultimately decreasing the risk of breast tumor development (65, 66). Here, OXT is linked to breast cancer.